Durham, NC, United States · North America
100sterile
OncologyRare diseaseCell & gene therapyVaccines
FDAEMAPMDANMPA
SCALE 270 studies
Loading…
Clinical Development
CROs
Clinical research organizations38
CROs listed
Trial management, monitoring, biostatistics and data services — scored on real operational depth, not sales polish.
Scores are deterministic, rules-based — not AI.
OncologyCell & gene therapyRare diseaseVaccines
NMPAFDAEMAPMDA
SCALE 270 studies
OncologyVaccinesRare disease
NMPAFDAEMAPMDA
SCALE 270 studies
Oncology
FDAEMAPMDANMPA
SCALE 270 studies
OncologyVaccines
PMDAFDAEMANMPA
SCALE 270 studies
OncologyInfectious diseaseVaccines
FDAEMAMHRAHealth Canada
SCALE 270 studies
Not stated as a therapeutic-area list. The company names immuno-oncology and T-cell biology as biologics/discovery focus areas; its offering is otherwise described by modality (small moleculespeptidesoligonucleotidesmAbs
FDA
SCALE 00 studies
Company lists: OncologyFibrosisRespiratory DiseasesNeuroscience
SCALE 20 studies
Stated on the company's Who We Are page: "multiple therapeutic areas with a specific focus on Inflammation & PainInfectious DiseasesCentral Nervous systemsand Oncology".
SCALE 00 studies